Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Feasibility and efficacy of CD19-targeted CAR T cells with concurrent ibrutinib for CLL after ibrutinib failure

Jordan Gauthier, Alexandre V. Hirayama, Janaki Purushe, Kevin A. Hay, James Lymp, Daniel H. Li, Cecilia C. S. Yeung, Alyssa Sheih, Barbara S. Pender, Reed M. Hawkins, Aesha Vakil, Tinh-Doan Phi, Rachel N. Steinmetz, Mazyar Shadman, Stanley R. Riddell, David G. Maloney, Cameron J. Turtle

Blood (2020) 135 (19): 1650–1660.

https://doi.org/10.1182/blood.2019002936

Published: 2020

Includes: Supplemental data

Journal Articles

Preemptive mitigation of CD19 CAR T-cell cytokine release syndrome without attenuation of antileukemic efficacy

Rebecca A. Gardner, Francesco Ceppi, Julie Rivers, Colleen Annesley, Corinne Summers, Agne Taraseviciute, Juliane Gust, Kasey J. Leger, Katherine Tarlock, Todd M. Cooper, Olivia C. Finney, Hannah Brakke, Daniel H. Li, Julie R. Park, Michael C. Jensen

Blood (2019) 134 (24): 2149–2158.

https://doi.org/10.1182/blood.2019001463

Published: 2019

Includes: Supplemental data

Journal Articles

Oral Fludarabine and Intravenous Rituximab (FR) for Chronic Lymphocytic Leukemia (CLL): Long Term Outcomes and Secondary Malignancies in 673 Patients Treated in British Columbia (BC)

Elysha Vanderveer, MD BSc, Steven J.T. Huang, BMLSc, Helene Bruyere, MD FCCMG, Tanya Gillan, PhD FCCMG, Charles H. Li, MDFRCPC, Khaled Ramadan, MBBCH, MRCP, FRCPath, Diego Villa, MD MPH, David W. Scott, MBChB, PhD, Kerry J Savage, BSc, MD MSc, Joseph M Connors, MD, Laurie H Sehn, MD, Cynthia L Toze, MD FRCPC, Alina S Gerrie, MD MPH

Blood (2019) 134 (Supplement_1): 4300.

https://doi.org/10.1182/blood-2019-125189

Published: 2019

Journal Articles

PU.1 and Spi-B Oppose Transformation Of Pre-B Cells Through Activation Of Key Genes Involved In B Cell Receptor Signalling

Darah A. Christie, PhD, Shereen A. Turkistany, Li S. Xu, PhD, Stephen K. H. Li, Ian Welch, DVM, Heather C. Broughton, Gillian I. Bell, David A. Hess, PhD, Rodney P. DeKoter, PhD

Blood (2013) 122 (21): 3737.

https://doi.org/10.1182/blood.V122.21.3737.3737

Published: 2013

Journal Articles

Genetic Predictors of Hemoglobin F Response to Hydroxyurea in Sickle Cell Anemia

Vivien A Sheehan, MD, PhD, Thad A Howard, MS, Aniko Sabo, PhD, Uma Nagasaswamy, PhD, Jacy R Crosby, MS, Brian Davis, MS, Alexander H Li, MS, Eric Boerwinkle, PhD, Richard A Gibbs, PhD, Russell E. Ware, MD, PhD, Jonathan M Flanagan, PhD

Blood (2012) 120 (21): 241.

https://doi.org/10.1182/blood.V120.21.241.241

Published: 2012

Journal Articles

Deletion of genes encoding PU.1 and Spi-B in B cells impairs differentiation and induces pre-B cell acute lymphoblastic leukemia

Kristen M. Sokalski, Stephen K. H. Li, Ian Welch, Heather-Anne T. Cadieux-Pitre, Marek R. Gruca, Rodney P. DeKoter

Blood (2011) 118 (10): 2801–2808.

https://doi.org/10.1182/blood-2011-02-335539

Published: 2011

Includes: Supplemental data

Journal Articles

A 3-bp deletion in the HBS1L-MYB intergenic region on chromosome 6q23 is associated with HbF expression

Blood (2011) 117 (18): 4935–4945.

https://doi.org/10.1182/blood-2010-11-317081

Published: 2011

Includes: Supplemental data

Journal Articles

Fludarabine (F) and Rituximab (R) (FR) as Initial Therapy for Symptomatic Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL): Population-Based Experience Matches Clinical Trials.

Alina S. Gerrie, MD, FRCPC, Cynthia L. Toze, MD, FRCP(C), Khaled M. Ramadan, MB, Charles H. Li, MD, Adrian Yee, MD, FRCPC, Joseph M. Connors, MD

Blood (2009) 114 (22): 2363.

https://doi.org/10.1182/blood.V114.22.2363.2363

Published: 2009

Journal Articles

Improved Survival of Patients with HIV-Related Systemic B-Cell Non-Hodgkin’s Lymphoma (NHL) Expressing the Epstein-Barr Virus (EBV) in Malignant Cells Provided Patients Received HAART with Lymphoma Therapy.

Hatoon Ezzat, MD, Douglas Filipinko, MD, Linda M. Vickars, MD, Paul F. Galbraith, MD, Charles H. Li, MD, Kevin Murphy, MD, Julio S.G. Montaner, MD, Marianne Harris, MD, Robert S. Hogg, MD, Suzanne Vercauteren, MD, Chantal S. Leger, MD, Leslie Zypchen, MD, Heather A. Leitch, MD, PhD

Blood (2006) 108 (11): 4666.

https://doi.org/10.1182/blood.V108.11.4666.4666

Published: 2006

Journal Articles

Improvement in Outcome of Patients with CD30+ HIV-Related Systemic B-Cell Non-Hodgkin’s Lymphoma (NHL) Providing HIV Infection Is Adequately Controlled.

Hatoon Ezzat, MD, Jonathan C. Wong, BHSc, Douglas Filipenko, MD, Linda M. Vickars, MD, Paul F. Galbraith, MD, Charles H. Li, MD, Kevin Murphy, MD, Julio S.G. Montaner, MD, Marianne Harris, MD, Robert S. Hogg, MD, Suzanne Vercauteren, MD, Chantal S. Leger, MD, Leslie Zypchen, MD, Heather A. Leitch, MD, PhD

Blood (2006) 108 (11): 4667.

https://doi.org/10.1182/blood.V108.11.4667.4667

Published: 2006

Journal Articles

Acute Leukemia in Patients Sixty Years of Age and Older: A Retrospective Review.

Chantal S. Leger, MD, Ann Lee, BSc, Heather A. Leitch, MD, PhD, Paul F. Galbraith, MD, Charles H. Li, MD, Linda M. Vickars, MD

Blood (2005) 106 (11): 4605.

https://doi.org/10.1182/blood.V106.11.4605.4605

Published: 2005

Journal Articles

BCL-2 Expression May Adversely Affect Outcome in HIV-Associated Systemic Diffuse Large B Cell Lymphoma.

Hatoon Ezzat, MD, J. Doug Filipenko, MD, Linda M. Vickars, MD, Paul F. Galbraith, MD, Charles H. Li, MD, Kevin Murphy, MD, Julio Montaner, MD, Marianne Harris, MD, Robert Hogg, MD, Suzanne Vercauteren, MD, Chantal S. Leger, MD, Leslie Zypchen, MD, Heather A. Leitch, MD, PhD

Blood (2005) 106 (11): 4674.

https://doi.org/10.1182/blood.V106.11.4674.4674

Published: 2005

Journal Articles

Presenting Features Predictive of Long-Term Stability in Chronic Lymphocytic Leukemia.

Kortney L. Hillier, BSc, Sarah S. Fung, BA, Linda M. Vickars, MD, Chantal S. Leger, MD, Paul F. Galbraith, MD, Charles H. Li, MD, Heather A. Leitch, MD, PhD

Blood (2005) 106 (11): 4982.

https://doi.org/10.1182/blood.V106.11.4982.4982

Published: 2005

Journal Articles

Clinical Progression and Outcome of Patients with Monoclonal Lymphocytosis of Undetermined Significance.

Sarah S. Fung, BA, Kortney L. Hillier, BSc, Linda M. Vickars, MD, Chantal S. Leger, MD, Paul F. Galbraith, MD, Charles H. Li, MD, Heather A. Leitch, MD, PhD

Blood (2005) 106 (11): 4983.

https://doi.org/10.1182/blood.V106.11.4983.4983

Published: 2005

Journal Articles

Overexpression of the myeloma-associated oncogene fibroblast growth factor receptor 3 confers dexamethasone resistance

Jonathan B. Pollett, Suzanne Trudel, Daniel Stern, Zhixiong H. Li, A. Keith Stewart

Blood (2002) 100 (10): 3819–3821.

https://doi.org/10.1182/blood-2002-02-0608

Published: 2002

Journal Articles

Temperature dependence of plasmin-induced activation or inhibition of human platelets

H Lu, C Soria, EM Cramer, J Soria, J Maclouf, JY Perrot, H Li, PL Commin, F Schumann, O Regnier

Blood (1991) 77 (5): 996–1005.

https://doi.org/10.1182/blood.V77.5.996.996

Published: 1991

NARROW

Feasibility and efficacy of CD19-targeted CAR T cells with concurrent ibrutinib for CLL after ibrutinib failure

Preemptive mitigation of CD19 CAR T-cell cytokine release syndrome without attenuation of antileukemic efficacy

Oral Fludarabine and Intravenous Rituximab (FR) for Chronic Lymphocytic Leukemia (CLL): Long Term Outcomes and Secondary Malignancies in 673 Patients Treated in British Columbia (BC)

PU.1 and Spi-B Oppose Transformation Of Pre-B Cells Through Activation Of Key Genes Involved In B Cell Receptor Signalling

Genetic Predictors of Hemoglobin F Response to Hydroxyurea in Sickle Cell Anemia

Deletion of genes encoding PU.1 and Spi-B in B cells impairs differentiation and induces pre-B cell acute lymphoblastic leukemia

A 3-bp deletion in the HBS1L-MYB intergenic region on chromosome 6q23 is associated with HbF expression

Fludarabine (F) and Rituximab (R) (FR) as Initial Therapy for Symptomatic Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL): Population-Based Experience Matches Clinical Trials.

Improved Survival of Patients with HIV-Related Systemic B-Cell Non-Hodgkin’s Lymphoma (NHL) Expressing the Epstein-Barr Virus (EBV) in Malignant Cells Provided Patients Received HAART with Lymphoma Therapy.

Improvement in Outcome of Patients with CD30+ HIV-Related Systemic B-Cell Non-Hodgkin’s Lymphoma (NHL) Providing HIV Infection Is Adequately Controlled.

Acute Leukemia in Patients Sixty Years of Age and Older: A Retrospective Review.

BCL-2 Expression May Adversely Affect Outcome in HIV-Associated Systemic Diffuse Large B Cell Lymphoma.

Presenting Features Predictive of Long-Term Stability in Chronic Lymphocytic Leukemia.

Clinical Progression and Outcome of Patients with Monoclonal Lymphocytosis of Undetermined Significance.

Overexpression of the myeloma-associated oncogene fibroblast growth factor receptor 3 confers dexamethasone resistance

Temperature dependence of plasmin-induced activation or inhibition of human platelets

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only